Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00941473 · ClinicalTrials.gov registry record · Phase 4
Effect of Epidural Steroid Injection on Bone Mineral Density in Postmenopausal Women
A Phase 4 study, sponsored by Henry Ford Health System.
- Completed
- Registry status
- Phase 4
- Development phase
- 28
- Enrollment target
NCT00941473 is a Phase 4 study that has completed, run by Henry Ford Health System. The registered enrollment target is 28 participants.
The verdict
NCT00941473, a Phase 4 study, has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 28 participants
- Enrollment target
Study Summary
To evaluate for the effect of corticosteroid epidural injections on bone mineral density in postmenopausal women. Candidates for the study: Post menopausal women between the ages of 55 and 80. No history of bone disease. No thyroid/parathyroid disorder. not used injected or oral steroids in the last year. No recent smoking. The purpose is to identify any significant change in bone mineral density with the use of epidural steroid injections. This may implicate the need for patient counseling regarding this possible side effect and the possible use of preventive measures to avoid this adverse effect.
Interventions
- DRUG Triamcinilone (kenalog)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2007-07 |
| Est. Completion | 2011-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00941473
The ClinicalTrials.gov registry entry for NCT00941473 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Triamcinilone (kenalog) is the first listed.
NCT00941473 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00941473 about?
NCT00941473 is a clinical study titled "Effect of Epidural Steroid Injection on Bone Mineral Density in Postmenopausal Women". To evaluate for the effect of corticosteroid epidural injections on bone mineral density in postmenopausal women. Candidates for the study: Post menopausal women between the ages of 55 and 80. No history of bone disease. No thyroid/parathyroid disorder. not used injected or oral steroids in the last...
What is the current status of trial NCT00941473?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 28 participants. The study started on 2007-07. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00941473?
The interventions under investigation include: Triamcinilone (kenalog) (DRUG).
Who is sponsoring clinical trial NCT00941473?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.